Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
Biomarker and diagnostic research for skin disorder has been reported in the published literature.
27 clinical trials registered, 11 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE4, 1 PHASE3, 5 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06923202](https://clinicaltrials.gov/study/NCT06923202) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 6:21 PM UTC
Study of Alloknesia in Atopic Dermatitis
— |
University Hospital, Brest |
RECRUITING |
[NCT06850311](https://clinicaltrials.gov/study/NCT06850311) | Herbal Ointment in Treating Atopic Dermatitis Topically | PHASE2 | En Chu Kong Hospital | RECRUITING |
[NCT03659227](https://clinicaltrials.gov/study/NCT03659227) | Drug Reactions Sampling (COLLECTIONTOXIDERMIES) | — | Assistance Publique - Hôpitaux de Paris | RECRUITING |
[NCT06037187](https://clinicaltrials.gov/study/NCT06037187) | Coagulopathy of Immunodermatologic Diseases | — | University of Nebraska | RECRUITING |
[NCT07209007](https://clinicaltrials.gov/study/NCT07209007) | Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients | — | Cho Yoon soo | RECRUITING |
444 publications have been identified in PubMed for skin disorder. Kisho has analyzed 352 by research type. Research spans Review / Meta-Analysis (44%), Basic Science / Preclinical (19%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 156 | 44% |
Laboratory research | 68 | 19% |
Patient case studies | 61 | 17% |
Disease patterns and progression | 23 | 7% |
New treatment approaches | 19 | 5% |
Clinical study results | 13 | 4% |
Testing and diagnosis research | 9 | 3% |
Other research | 3 | 1% |
Tian X (2026). [PMID: 41780419](https://pubmed.ncbi.nlm.nih.gov/41780419/). *Phytomedicine*. [Gene Therapy / Novel Therapeutics]
Hao L (2026). [PMID: 41809386](https://pubmed.ncbi.nlm.nih.gov/41809386/). *Mater Today Bio*. [Gene Therapy / Novel Therapeutics]
Leti M (2026). [PMID: 41042734](https://pubmed.ncbi.nlm.nih.gov/41042734/). *Dermatology*. [Review / Meta-Analysis]
Glennon CM (2026). [PMID: 41251635](https://pubmed.ncbi.nlm.nih.gov/41251635/). *American journal of kidney diseases : the official journal of the National Kidney Foundation*. [Epidemiology / Natural History]
Mitra R (2026). [PMID: 40765039](https://pubmed.ncbi.nlm.nih.gov/40765039/). *J Drug Target*. [Review / Meta-Analysis]
Shareef S (2026). [PMID: 30969634](https://pubmed.ncbi.nlm.nih.gov/30969634/). *Unknown Journal*. [Case Report / Case Series]
Mörbe UM (2026). [PMID: 41379085](https://pubmed.ncbi.nlm.nih.gov/41379085/). *J Exp Med*. [Basic Science / Preclinical]
Kasperkiewicz M (2026). [PMID: 40853220](https://pubmed.ncbi.nlm.nih.gov/40853220/). *Br J Dermatol*. [Review / Meta-Analysis]
Tang Z (2026). [PMID: 41835962](https://pubmed.ncbi.nlm.nih.gov/41835962/). *Clin Cosmet Investig Dermatol*. [Case Report / Case Series]
Mai SZ (2026). [PMID: 41549598](https://pubmed.ncbi.nlm.nih.gov/41549598/). *J Dtsch Dermatol Ges*. [Case Report / Case Series]